186 related articles for article (PubMed ID: 18923447)
1. SOX9 and SOX10 but not BRN2 are required for nestin expression in human melanoma cells.
Flammiger A; Besch R; Cook AL; Maier T; Sturm RA; Berking C
J Invest Dermatol; 2009 Apr; 129(4):945-53. PubMed ID: 18923447
[TBL] [Abstract][Full Text] [Related]
2. Nestin and SOX9 and SOX10 transcription factors are coexpressed in melanoma.
Bakos RM; Maier T; Besch R; Mestel DS; Ruzicka T; Sturm RA; Berking C
Exp Dermatol; 2010 Aug; 19(8):e89-94. PubMed ID: 19845757
[TBL] [Abstract][Full Text] [Related]
3. Co-expression of SOX9 and SOX10 during melanocytic differentiation in vitro.
Cook AL; Smith AG; Smit DJ; Leonard JH; Sturm RA
Exp Cell Res; 2005 Aug; 308(1):222-35. PubMed ID: 15896776
[TBL] [Abstract][Full Text] [Related]
4. Interplay of SOX and POU factors in regulation of the Nestin gene in neural primordial cells.
Tanaka S; Kamachi Y; Tanouchi A; Hamada H; Jing N; Kondoh H
Mol Cell Biol; 2004 Oct; 24(20):8834-46. PubMed ID: 15456859
[TBL] [Abstract][Full Text] [Related]
5. Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma.
Shakhova O; Cheng P; Mishra PJ; Zingg D; Schaefer SM; Debbache J; Häusel J; Matter C; Guo T; Davis S; Meltzer P; Mihic-Probst D; Moch H; Wegner M; Merlino G; Levesque MP; Dummer R; Santoro R; Cinelli P; Sommer L
PLoS Genet; 2015 Jan; 11(1):e1004877. PubMed ID: 25629959
[TBL] [Abstract][Full Text] [Related]
6. SOX9 is a dose-dependent metastatic fate determinant in melanoma.
Yang X; Liang R; Liu C; Liu JA; Cheung MPL; Liu X; Man OY; Guan XY; Lung HL; Cheung M
J Exp Clin Cancer Res; 2019 Jan; 38(1):17. PubMed ID: 30642390
[TBL] [Abstract][Full Text] [Related]
7. Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor.
Boyle GM; Woods SL; Bonazzi VF; Stark MS; Hacker E; Aoude LG; Dutton-Regester K; Cook AL; Sturm RA; Hayward NK
Pigment Cell Melanoma Res; 2011 Jun; 24(3):525-37. PubMed ID: 21435193
[TBL] [Abstract][Full Text] [Related]
8. POU domain transcription factors: BRN2 as a regulator of melanocytic growth and tumourigenesis.
Cook AL; Sturm RA
Pigment Cell Melanoma Res; 2008 Dec; 21(6):611-26. PubMed ID: 18983536
[TBL] [Abstract][Full Text] [Related]
9. POU domain transcription factor BRN2 is crucial for expression of ASCL1, ND1 and neuroendocrine marker molecules and cell growth in small cell lung cancer.
Ishii J; Sato H; Sakaeda M; Shishido-Hara Y; Hiramatsu C; Kamma H; Shimoyamada H; Fujiwara M; Endo T; Aoki I; Yazawa T
Pathol Int; 2013 Mar; 63(3):158-68. PubMed ID: 23530560
[TBL] [Abstract][Full Text] [Related]
10. Cell-cycle-specific nestin expression coordinates with morphological changes in embryonic cortical neural progenitors.
Sunabori T; Tokunaga A; Nagai T; Sawamoto K; Okabe M; Miyawaki A; Matsuzaki Y; Miyata T; Okano H
J Cell Sci; 2008 Apr; 121(Pt 8):1204-12. PubMed ID: 18349072
[TBL] [Abstract][Full Text] [Related]
11. Different transcription factors regulate nestin gene expression during P19 cell neural differentiation and central nervous system development.
Jin Z; Liu L; Bian W; Chen Y; Xu G; Cheng L; Jing N
J Biol Chem; 2009 Mar; 284(12):8160-73. PubMed ID: 19147497
[TBL] [Abstract][Full Text] [Related]
12. BRN2 is a non-canonical melanoma tumor-suppressor.
Hamm M; Sohier P; Petit V; Raymond JH; Delmas V; Le Coz M; Gesbert F; Kenny C; Aktary Z; Pouteaux M; Rambow F; Sarasin A; Charoenchon N; Bellacosa A; Sanchez-Del-Campo L; Mosteo L; Lauss M; Meijer D; Steingrimsson E; Jönsson GB; Cornell RA; Davidson I; Goding CR; Larue L
Nat Commun; 2021 Jun; 12(1):3707. PubMed ID: 34140478
[TBL] [Abstract][Full Text] [Related]
13. BRN2 suppresses apoptosis, reprograms DNA damage repair, and is associated with a high somatic mutation burden in melanoma.
Herbert K; Binet R; Lambert JP; Louphrasitthiphol P; Kalkavan H; Sesma-Sanz L; Robles-Espinoza CD; Sarkar S; Suer E; Andrews S; Chauhan J; Roberts ND; Middleton MR; Gingras AC; Masson JY; Larue L; Falletta P; Goding CR
Genes Dev; 2019 Mar; 33(5-6):310-332. PubMed ID: 30804224
[TBL] [Abstract][Full Text] [Related]
14. Nestin is highly expressed in advanced-stage melanomas and neurotized nevi.
Akiyama M; Matsuda Y; Ishiwata T; Naito Z; Kawana S
Oncol Rep; 2013 Apr; 29(4):1595-9. PubMed ID: 23417116
[TBL] [Abstract][Full Text] [Related]
15. Control of myelination in Schwann cells: a Krox20 cis-regulatory element integrates Oct6, Brn2 and Sox10 activities.
Ghislain J; Charnay P
EMBO Rep; 2006 Jan; 7(1):52-8. PubMed ID: 16311519
[TBL] [Abstract][Full Text] [Related]
16. Sox9 and Sox10 influence survival and migration of oligodendrocyte precursors in the spinal cord by regulating PDGF receptor alpha expression.
Finzsch M; Stolt CC; Lommes P; Wegner M
Development; 2008 Feb; 135(4):637-46. PubMed ID: 18184726
[TBL] [Abstract][Full Text] [Related]
17. Expression of the neuroectodermal intermediate filament nestin in human melanomas.
Flørenes VA; Holm R; Myklebost O; Lendahl U; Fodstad O
Cancer Res; 1994 Jan; 54(2):354-6. PubMed ID: 8275467
[TBL] [Abstract][Full Text] [Related]
18. SOX10 induced Nestin expression regulates cancer stem cell properties of TNBC cells.
Feng W; Liu S; Zhu R; Li B; Zhu Z; Yang J; Song C
Biochem Biophys Res Commun; 2017 Apr; 485(2):522-528. PubMed ID: 28189679
[TBL] [Abstract][Full Text] [Related]
19. Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 Activation.
Zeng H; Jorapur A; Shain AH; Lang UE; Torres R; Zhang Y; McNeal AS; Botton T; Lin J; Donne M; Bastian IN; Yu R; North JP; Pincus L; Ruben BS; Joseph NM; Yeh I; Bastian BC; Judson RL
Cancer Cell; 2018 Jul; 34(1):56-68.e9. PubMed ID: 29990501
[TBL] [Abstract][Full Text] [Related]
20. Sox9 and Sox8 are required for basal lamina integrity of testis cords and for suppression of FOXL2 during embryonic testis development in mice.
Georg I; Barrionuevo F; Wiech T; Scherer G
Biol Reprod; 2012 Oct; 87(4):99. PubMed ID: 22837482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
